SCHEMBL20302817

SCHEMBL20302817

CC1CCN(S(=O)(=O)c2ccc3c(c2)C(=NO)c2cc(S(=O)(=O)N4CCC(C)CC4)ccc2-3)CC1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 1.00
▸ NPC1 O15118 2/20 1.00
▸ MAPT P10636 2/20 1.00
▸ HPGD P15428 2/20 1.00
▸ HTT P42858 2/20 1.00
▸ RAB9A P51151 2/20 1.00
▸ SMN1; SMN2 Q16637 2/20 1.00
▸ NPSR1 Q6W5P4 2/20 1.00
▸ CYP2C9 P11712 1/20 1.00
▸ XBP1 P17861 1/20 1.00
▸ CYP2C19 P33261 1/20 1.00
▸ LMNA P02545 4/20 0.71
▸ ALDH1A1 P00352 3/20 0.71
▸ TDP1 Q9NUW8 2/20 0.71
▸ POLB P06746 2/20 0.71
▸ HSD17B10 Q99714 2/20 0.71
▸ TP53 P04637 1/20 0.71
▸ TSHR P16473 1/20 0.71
▸ PAX8 Q06710 1/20 0.71
▸ MEN1 O00255 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20302771 0.88 KDM4E (0.78) KDM4ENPC1MAPTHPGDHTT
SCHEMBL20302758 0.86 MAPT (0.75) KDM4ENPC1MAPTHPGDHTT
SCHEMBL20302756 0.84 KDM4E (0.72) KDM4ENPC1MAPTHPGDHTT
SCHEMBL20302801 0.84 KDM4E (0.72) KDM4ENPC1MAPTHPGDHTT
SCHEMBL15540128 0.83 MAPT (1.00) KDM4ENPC1MAPTHPGDHTT
SCHEMBL29675943 0.83 MAPT (1.00) KDM4ENPC1MAPTHPGDHTT
SCHEMBL20302789 0.82 KDM4E (0.69) KDM4ENPC1MAPTHPGDHTT
Tegavivint SCHEMBL14947676 0.81 NPSR1 (0.68) KDM4ENPC1MAPTHPGDHTT
SCHEMBL13366831 0.81 NPSR1 (0.68) KDM4ENPC1MAPTHPGDHTT
Tegavivint SCHEMBL31694538 0.81 NPSR1 (0.68) KDM4ENPC1MAPTHPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10947188-B2 Small molecule ferroptosis inducers THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2021-03-16 — — US disclosed
US-10947188-B2 Small molecule ferroptosis inducers THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2021-03-16 — — US disclosed
US-20190315681-A1 SMALL MOLECULE FERROPTOSIS INDUCERS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2019-10-17 — — US disclosed
US-20190315681-A1 SMALL MOLECULE FERROPTOSIS INDUCERS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK 2019-10-17 — — US disclosed
WO-2018118711-A1 SMALL MOLECULE FERROPTOSIS INDUCERS THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 2018-06-28 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10947188-B2 Small molecule ferroptosis inducers GPX4, AIFM2, GPX1 KDM4E 2315/4885NPC1 365/4885MAPT 4344/4885
US-20190315681-A1 SMALL MOLECULE FERROPTOSIS INDUCERS GPX4, AIFM2, GPX1 KDM4E 2315/4885NPC1 365/4885MAPT 4344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback